CEO of Dynamis Corporation
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Vice president, chief strategy and operating officer of the Texas Medical Center
Recent breakthroughs have enabled E. Edward Baetge’s team at San Diego-based Novocell to develop and patent an innovative stem cell therapy that yields functional pancreatic, insulin-producing cells using human embryonic stem cells. Baetge outlines development of a potential therapy that injects such stem cells into the bodies of diabetics to replace cells that no longer produce insulin. More information and online registration is available here.